PL2155682T3 - Sole iperytu izofosforamidowego i ich analogi - Google Patents
Sole iperytu izofosforamidowego i ich analogiInfo
- Publication number
- PL2155682T3 PL2155682T3 PL08727299T PL08727299T PL2155682T3 PL 2155682 T3 PL2155682 T3 PL 2155682T3 PL 08727299 T PL08727299 T PL 08727299T PL 08727299 T PL08727299 T PL 08727299T PL 2155682 T3 PL2155682 T3 PL 2155682T3
- Authority
- PL
- Poland
- Prior art keywords
- analogs
- salts
- isophosphoramide mustard
- isophosphoramide
- mustard
- Prior art date
Links
- BKCJZNIZRWYHBN-UHFFFAOYSA-N Isophosphamide mustard Chemical class ClCCNP(=O)(O)NCCCl BKCJZNIZRWYHBN-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Seasonings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92214807P | 2007-04-06 | 2007-04-06 | |
US92736307P | 2007-05-02 | 2007-05-02 | |
US93491407P | 2007-06-15 | 2007-06-15 | |
US123707P | 2007-10-30 | 2007-10-30 | |
EP08727299.3A EP2155682B1 (en) | 2007-04-06 | 2008-04-04 | Salts of isophosphoramide mustard and analogs thereof |
PCT/US2008/004449 WO2008124097A2 (en) | 2007-04-06 | 2008-04-04 | Salts of isophosphoramide mustard and analogs thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2155682T3 true PL2155682T3 (pl) | 2015-12-31 |
Family
ID=39387443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08727299T PL2155682T3 (pl) | 2007-04-06 | 2008-04-04 | Sole iperytu izofosforamidowego i ich analogi |
Country Status (22)
Country | Link |
---|---|
US (2) | US8604007B2 (pl) |
EP (2) | EP2581367B1 (pl) |
JP (1) | JP5659010B2 (pl) |
KR (3) | KR101604244B1 (pl) |
CN (2) | CN101679265B (pl) |
AU (1) | AU2008236684B2 (pl) |
BR (1) | BRPI0809999A2 (pl) |
CA (1) | CA2684747A1 (pl) |
CY (1) | CY1116596T1 (pl) |
DK (2) | DK2155682T3 (pl) |
ES (1) | ES2547302T3 (pl) |
HU (1) | HUE025949T2 (pl) |
IL (2) | IL201424A (pl) |
MX (1) | MX2009010820A (pl) |
NZ (1) | NZ580341A (pl) |
PL (1) | PL2155682T3 (pl) |
PT (2) | PT2155682E (pl) |
RU (1) | RU2527531C2 (pl) |
SI (1) | SI2155682T1 (pl) |
TW (2) | TWI490226B (pl) |
WO (1) | WO2008124097A2 (pl) |
ZA (1) | ZA200907722B (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678778B2 (en) | 2004-10-25 | 2010-03-16 | Dekk-Tec, Inc. | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
US7964583B2 (en) * | 2006-02-17 | 2011-06-21 | Ziopharm Oncology, Inc. | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
JP5659010B2 (ja) | 2007-04-06 | 2015-01-28 | ジオファーム オンコロジー, インコーポレイテッドZiopharm Oncology,Inc. | イソホスホルアミドマスタードの塩およびそれらの類似体 |
NZ590995A (en) | 2008-07-31 | 2012-12-21 | Ziopharm Oncology Inc | Oral formulations of salts of isophosphoramide mustard and its analogs and their use in the treatment of a condition characterised by abnormal cell growth or differentiation (such as cancer) |
AU2010218109B2 (en) * | 2009-02-24 | 2015-04-09 | Dekk-Tec, Inc. | Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents |
WO2013116281A1 (en) * | 2012-01-31 | 2013-08-08 | Ziopharm Oncology, Inc. | Combination therapy including isophosphoramide mustard, analogs, or salts thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU427945A1 (ru) | 1972-07-24 | 1974-05-15 | Институт элементоорганических соединений | СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ |
JPS5159886A (pl) | 1974-11-20 | 1976-05-25 | Shionogi Seiyaku Kk | |
US4537883A (en) * | 1982-11-12 | 1985-08-27 | Mead Johnson & Company | Lyophilized cyclophosphamide |
US5091552A (en) * | 1986-06-30 | 1992-02-25 | Board Of Regents, The University Of Texas System | Novel antitumor aldophosphamide analogs |
US5055459A (en) * | 1986-06-30 | 1991-10-08 | Board Of Regents, The University Of Texas | Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates |
US5204335A (en) * | 1986-10-31 | 1993-04-20 | Asta Pharma Aktiengesellschaft | Ifosfamide lyophilisate and process for its preparation |
CA2130578A1 (en) | 1992-04-17 | 1993-10-28 | Geewananda P. Gunawardana | Taxol derivatives |
US5468499A (en) * | 1993-11-15 | 1995-11-21 | Ohio State University | Liposomes containing the salt of phosphoramide mustard and related compounds |
US5659061A (en) * | 1995-04-20 | 1997-08-19 | Drug Innovation & Design, Inc. | Tumor protease activated prodrugs of phosphoramide mustard analogs with toxification and detoxification functionalities |
ES2257756T3 (es) * | 1996-03-12 | 2006-08-01 | Sanofi-Aventis Deutschland Gmbh | Nuevos profarmacos para la terapia de tumores y enfermedades inflamatorias. |
US5912264A (en) | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
DE60007120T2 (de) | 1999-05-24 | 2004-09-16 | Southern Research Institute, Birmingham | Isophosphoramide-senfgasanalogen und deren verwendung |
AR030188A1 (es) | 2000-02-02 | 2003-08-13 | Univ Florida State Res Found | Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos |
US7012095B2 (en) | 2000-04-13 | 2006-03-14 | Hsc Research And Development Limited | Compounds for modulating cell proliferation |
SI1767535T1 (sl) | 2002-08-23 | 2010-03-31 | Sloan Kettering Inst Cancer | Sinteza epotilonov njihovih intermediatov analogov in uporaba le teh |
US7678778B2 (en) * | 2004-10-25 | 2010-03-16 | Dekk-Tec, Inc. | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
JP5659010B2 (ja) | 2007-04-06 | 2015-01-28 | ジオファーム オンコロジー, インコーポレイテッドZiopharm Oncology,Inc. | イソホスホルアミドマスタードの塩およびそれらの類似体 |
-
2008
- 2008-04-04 JP JP2010502149A patent/JP5659010B2/ja not_active Expired - Fee Related
- 2008-04-04 MX MX2009010820A patent/MX2009010820A/es active IP Right Grant
- 2008-04-04 WO PCT/US2008/004449 patent/WO2008124097A2/en active Application Filing
- 2008-04-04 CN CN200880018371.5A patent/CN101679265B/zh not_active Expired - Fee Related
- 2008-04-04 BR BRPI0809999-5A2A patent/BRPI0809999A2/pt not_active IP Right Cessation
- 2008-04-04 DK DK08727299.3T patent/DK2155682T3/en active
- 2008-04-04 ES ES08727299.3T patent/ES2547302T3/es active Active
- 2008-04-04 HU HUE08727299A patent/HUE025949T2/en unknown
- 2008-04-04 CN CN201210399034.3A patent/CN102942589B/zh not_active Expired - Fee Related
- 2008-04-04 RU RU2009140904/04A patent/RU2527531C2/ru not_active IP Right Cessation
- 2008-04-04 PL PL08727299T patent/PL2155682T3/pl unknown
- 2008-04-04 EP EP13150037.3A patent/EP2581367B1/en not_active Not-in-force
- 2008-04-04 PT PT87272993T patent/PT2155682E/pt unknown
- 2008-04-04 PT PT131500373T patent/PT2581367E/pt unknown
- 2008-04-04 KR KR1020137008586A patent/KR101604244B1/ko not_active IP Right Cessation
- 2008-04-04 KR KR1020097023032A patent/KR101505415B1/ko not_active IP Right Cessation
- 2008-04-04 KR KR1020157033501A patent/KR20150139620A/ko not_active Application Discontinuation
- 2008-04-04 CA CA002684747A patent/CA2684747A1/en not_active Abandoned
- 2008-04-04 US US12/080,812 patent/US8604007B2/en not_active Expired - Fee Related
- 2008-04-04 DK DK13150037.3T patent/DK2581367T3/en active
- 2008-04-04 AU AU2008236684A patent/AU2008236684B2/en not_active Ceased
- 2008-04-04 NZ NZ580341A patent/NZ580341A/en not_active IP Right Cessation
- 2008-04-04 SI SI200831503T patent/SI2155682T1/sl unknown
- 2008-04-04 EP EP08727299.3A patent/EP2155682B1/en not_active Not-in-force
- 2008-04-07 TW TW097112572A patent/TWI490226B/zh not_active IP Right Cessation
- 2008-04-07 TW TW102136735A patent/TWI501972B/zh not_active IP Right Cessation
-
2009
- 2009-10-11 IL IL201424A patent/IL201424A/en not_active IP Right Cessation
- 2009-11-03 ZA ZA2009/07722A patent/ZA200907722B/en unknown
-
2012
- 2012-11-29 IL IL223353A patent/IL223353A/en not_active IP Right Cessation
-
2013
- 2013-11-06 US US14/072,934 patent/US9340563B2/en not_active Expired - Fee Related
-
2015
- 2015-09-23 CY CY20151100839T patent/CY1116596T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2150109A4 (en) | PHARMACEUTICAL USE OF SUBSTITUTED AMIDES | |
ZA201006386B (en) | Preparation of desulphurisation materials | |
LT3222617T (lt) | Psma nukreipti junginiai ir jų naudojimas | |
HK1167857A1 (en) | Antiviral compounds and uses thereof | |
IL200013A0 (en) | Indenoisoquinolinone analogs and methods of use thereof | |
PL2133419T3 (pl) | Zastosowania beta-dipeptydów cyjanoficyny | |
IL223353A0 (en) | Salts of isophosphoramide mustard and analogs thereof | |
IL248077A0 (en) | Formulations, salts and polymers of transnorsertraline and their uses | |
HK1160925A1 (zh) | 組織蛋白酶 的用途 | |
ZA201100878B (en) | Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof | |
PL2493496T3 (pl) | Zastosowanie GSTP1 | |
IL196320A0 (en) | Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones | |
HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
IL210956A0 (en) | Methionine analogs and methods of using same | |
GB201114396D0 (en) | Location of basesation | |
PL2346485T3 (pl) | Stosowanie betainy | |
GB0911709D0 (en) | Stoma bridge | |
ZA200810632B (en) | Derivativs and analogs of N-ethylquinolones and N-ethylazaquinolones | |
GB0706347D0 (en) | Purification of salts | |
PL383759A1 (pl) | Nowe zastosowanie undekan-2-olu | |
PL383760A1 (pl) | Nowe zastosowanie undekan-2-olu | |
PL383758A1 (pl) | Nowe zastosowanie undekan-2-onu | |
GB0705204D0 (en) | Uses of (S)-clenbuterol | |
HU0800656D0 (en) | Effective use of tea-composition | |
HU0900647D0 (en) | Salts of 7-nitroindoline derivatives and use thereof |